Riccardo Panella

Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy.

Innogest SGR SpA (Innogest) is a private equity firm founded in 2005 by Claudio Giuliano and Marco Pinciroli. The firm is headquartered in Milan, Italy.

St. Thomas Hospital, Inc. operates hospitals. The private company is based in St. Thomas, VI. and has subsidiaries in United States.

Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA.

F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom.

Kent County Memorial Hospital provides health care services. It also provides inpatient services including cardiology and extended coronary care, infectious disease, primary care, oncology, orthopedics, obstetrics and gynecology, pediatrics, rehabilitation and surgery. The company was founded in 1951 and is headquartered in Warwick, RI.

Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark.

Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York.

Italian Angels for Growth (IAG)is an venture capital firm founded in 2007 by Andrea Mandel Mantello, Antonio Sfiligoj, Enrico Castellano, Francesco Marini Clarelli, Lorenzo Franchini, Luigi Amati, Luigi Capello, Marco Asquini and Marco Villa. The firm is headquartered in Milan, Italy.

CellPly SRL develops and markets customized diagnostic tools for cancer treatment. The firm specializes in the design and marketing of solutions for defining the efficacy of immunotherapies and chemotherapies on cancer and immune cells. It offers a platform that analyzes ex-vivo samples and rare cells immediately after obtaining them from patients and preserving microenvironment conditions to readily provide information about tumor cell sensitivity to drugs and in-vivo status of single immune cells located close to tumor cells. The firm focuses on helping oncologists selecting the best treatment options, scientists studying cell response to therapy, and pharmaceutical companies increasing drug efficacy and rescuing drugs with limited efficacy through patient stratification. The company was founded by Massimo Bocchi and Roberto Guerrieri in 2013 and is headquartered in Bologna, Italy.

Olympus Group, Inc. provides civil engineering services. It services include civil engineering, which include multi-family podium, commercial, retail and industrial, single and multi family residential, earthworks, infrastructure studies and sewer capacity analysis and planning, surveying and specialty services. The company was founded on October 16, 2009 and is headquartered in Orangevale, CA.

Bellco SRL provides therapies and systems for the treatment of renal failure, multiple organ failure, sepsis and congestive heart failure. It offers haemodiafiltration therapies, dialysis machines equipment, haemodialysers, blood lines, catheters, concentrates, and sorbent cartridges; pathologies for acute patients; and altered haemodynamics, renal hypoperfusion, and low cardiac output therapeutic system for neonatal patients. The company was founded in 1972 and is headquartered in Mirandola, Italy.^

Repron Therapeutics Srl is an Italian company that operates as an epigenetic silencing platform for tumor recurrence repression. The company is based in Milan, Italy. The company was founded by Alessandro Sessa and Vania Broccoli.

Magneti Marelli After Market Parts & Services SpA sells and distributes automotive spare parts and components. The firm offers parts for maintenance, repair, and collision. It also provides related services such as training, fleet and insurance management, and tutorship. The company is headquartered in Milan, Italy.

NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom.

Heqet Therapeutics SRL is an Italian biotechnology company that specializes in cardiac regenerative medicine. The company is based in Turin, Italy. The company was founded by Mauro Giacca. Marta Antonucci has been the CEO of the company since 2022.